Alnylam Pharmaceuticals | ALNY - Stock

Stock Price
302.68
Daily Change
0.57 0.19%
Monthly
-4.24%
Yearly
14.98%
Q2 Forecast
299.00

Alnylam Pharmaceuticals reported $82.72M in Stock for its fiscal quarter ending in December of 2025.





Stock Change Date
Acadia Pharmaceuticals USD 34.67M 5.57M Dec/2025
Agios Pharmaceuticals USD 35.09M 2.17M Mar/2026
Alnylam Pharmaceuticals USD 82.72M 7.34M Dec/2025
Amgen USD 6.22B 121M Dec/2025
Arrowhead Research USD -173.08M 173.08M Dec/2024
BioCryst Pharmaceuticals USD 5.4M 166K Dec/2025
BioMarin Pharmaceutical USD 1.3B 83.29M Dec/2025
Incyte USD 115.62M 14.56M Mar/2026
Ionis Pharmaceuticals USD 10.05M 422K Dec/2025
Moderna USD 332M 92M Sep/2025
Neurocrine Biosciences USD 69M 300K Dec/2025
Novartis USD 6.42B 114M Sep/2025
PTC Therapeutics USD 79.65M 26.96M Dec/2025
Regeneron Pharmaceuticals USD 3.1B 97.2M Mar/2026
Sanofi EUR 22.69B 1.81B Dec/2025
Sarepta Therapeutics USD 914.74M 162.42M Dec/2025
Takeda JPY 1.41T 107.71B Dec/2025
Ultragenyx Pharmaceutical USD 52.2M 5.7M Sep/2025
Vertex Pharmaceuticals USD 1.69B 60M Dec/2025